About Our Research
Welcome to the UF Diabetes Institute. We are passionate about our clinical research, and would like to offer you as much information as possible about the exciting possibility of you volunteering for research. By becoming a research participant, you will partner with us in gaining new knowledge for our ultimate goal: improving the lives of people with diabetes.
For more information about our current studies at the University of Florida, please explore our current research studies or contact Annie Abraham at (352) 334-1358.
The UF Diabetes Institute is a leader in clinical trials seeking to prevent or reverse the disease. Since its inception, over 3,500 patients have participated in one or more of the UF Diabetes Institute’s clinical trials or studies. Based on success, our researchers have the opportunity to take their research findings further.
Clinical trials are a partnership between people affected by diabetes and doctors to help find ways to treat, predict, prevent, and reverse the disease. These trials seek to improve day-to-day diabetes management and prevent diabetes-related complications. Each study tries to answer specific scientific questions. Clinical trials that involve patients are the final stage of careful and extensive diabetes research taking place in the laboratory. Participants in clinical trials are offered the opportunity to play a more active role in their own health care, learn about new research treatments, and help others by contributing to medical research.
Funding for our studies comes from a variety of sponsors, including the National Institutes of Health, the Juvenile Diabetes Research Foundation, the American Diabetes Association, and The Helmsley Trust.
Each clinical trial is approved and monitored by the UF Institutional Review Board (IRB) to make sure the risks are as low as possible and are worth any potential benefits. An IRB is an independent committee of physicians, statisticians, community advocates, and others that ensures that the rights of the participants are protected and that the study is ethical.